日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Molecular determinants of STEC-HUS: from complement activation to microvascular thrombosis

STEC-HUS的分子决定因素:从补体激活到微血管血栓形成

Santarsiero, Donata; Galbusera, Miriam; Gastoldi, Sara; Bresin, Elena; Piras, Rossella; Alberti, Marta; Vivarelli, Marina; Prandini, Silvia; Conti, Sara; Zotta, Federica; Schubart, Anna; Benigni, Ariela; Remuzzi, Giuseppe; Noris, Marina; Aiello, Sistiana

Complement Alternative Pathway Dominance in Atypical Hemolytic Uremic Syndrome Revealed by Endothelial Bioassays

内皮细胞生物测定揭示非典型溶血性尿毒综合征中补体替代途径的优势

Santarsiero, Donata; Gastoldi, Sara; Guaschino, Valeria; Bresin, Elena; Pagani, Ilaria; Pasini, Andrea; Romano, Elena; Benigni, Ariela; Remuzzi, Giuseppe; Noris, Marina; Aiello, Sistiana

Response to the Letter to the Editor Entitled "Defining "Dominance" in Atypical Hemolytic Uremic Syndrome: Distinguishing Amplification From Initiation"

对题为“定义非典型溶血性尿毒综合征中的‘优势’:区分扩增与启动”的读者来信的回应

Aiello, Sistiana; Santarsiero, Donata; Gastoldi, Sara; Benigni, Ariela; Remuzzi, Giuseppe; Noris, Marina

Mesenchymal stromal cell secretome reduces lung injury and thrombo-inflammation induced by SARS-CoV-2 spike protein.

间充质基质细胞分泌组可减轻SARS-CoV-2刺突蛋白引起的肺损伤和血栓炎症

Pezzotta Anna, Bovio Alessandra, Imberti Barbara, Locatelli Monica, Corna Daniela, Cerullo Domenico, Gastoldi Sara, Benigni Ariela, Remuzzi Giuseppe, Morigi Marina, Perico Luca

C3d-targeted complement inhibitors to correct complement dysregulation in aHUS patients

靶向C3d的补体抑制剂用于纠正非典型溶血性尿毒综合征(aHUS)患者的补体失调

Guaschino, Valeria; Santarsiero, Donata; Gastoldi, Sara; Thurman, Joshua M; Holers, V Michael; Violette, Shelia M; Liu, Fei; Fahnoe, Kelly C; Guarinoni, Chiara; Benigni, Ariela; Remuzzi, Giuseppe; Noris, Marina; Aiello, Sistiana

Case report: Timing of eculizumab treatment in catastrophic antiphospholipid syndrome

病例报告:灾难性抗磷脂综合征中依库珠单抗治疗的时机

Carrara, Camillo; Mataj, Blerina; Gastoldi, Sara; Ruggenenti, Piero; Sciascia, Savino; Roccatello, Dario

Exuberant Endothelial C5b-9 Formation in Recurrent and De Novo Posttransplant Thrombotic Microangiopathy

复发性和新发移植后血栓性微血管病中内皮细胞C5b-9过度形成

Aiello, Sistiana; Gastoldi, Sara; Bresin, Elena; Galbusera, Miriam; Mele, Caterina; Daina, Erica; Santarsiero, Donata; Comai, Giorgia; La Manna, Gaetano; Martinatto, Carolina; Benigni, Ariela; Remuzzi, Giuseppe; Noris, Marina

C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19

C5a 和 C5aR1 是多种临床疾病(从非典型溶血性尿毒综合征到 COVID-19)中微血管血小板聚集的关键驱动因素。

Aiello, Sistiana; Gastoldi, Sara; Galbusera, Miriam; Ruggenenti, Piero; Portalupi, Valentina; Rota, Stefano; Rubis, Nadia; Liguori, Lucia; Conti, Sara; Tironi, Matteo; Gamba, Sara; Santarsiero, Donata; Benigni, Ariela; Remuzzi, Giuseppe; Noris, Marina

Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis

病例报告:双重过滤血浆置换法获得的抗SARS-CoV-2康复抗体的作用

Curtò, Diego; Tomatis, Federica; Gastoldi, Sara; Galbusera, Miriam; Noris, Marina; Raimondi, Federico; Lorini, Ferdinando Luca; Falanga, Anna; Marchetti, Marina; Remuzzi, Giuseppe; Ruggenenti, Piero

Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study

依库珠单抗治疗需要持续气道正压通气支持的重症冠状病毒病 (COVID-19) 患者:回顾性队列研究

Ruggenenti, Piero; Di Marco, Fabiano; Cortinovis, Monica; Lorini, Luca; Sala, Silvia; Novelli, Luca; Raimondi, Federico; Gastoldi, Sara; Galbusera, Miriam; Donadelli, Roberta; Mele, Caterina; Piras, Rossella; Noris, Marina; Portalupi, Valentina; Cappelletti, Laura; Carrara, Camillo; Tomatis, Federica; Bernardi, Silvia; Perna, Annalisa; Peracchi, Tobia; Diadei, Olimpia; Benigni, Ariela; Remuzzi, Giuseppe